- Joined
- Jul 2, 2008
- Messages
- 9,156
ahh I see thanks for clearing that up ebola
N&PD Moderators: Skorpio | thegreenhand
It's almost like the authors are responding directly to your question:
Stimulants and Cardiovascular Events in Youth With Attention-Deficit/Hyperactivity Disorder
http://www.sciencedirect.com/science/article/pii/S0890856711010495
The only greater danger that MPH possesses over amphetamine largely stems from its higher propensity for readministration and intranasal abuse. Aside from this, I am not aware of any significant differences when used in therapeutic doses. I personally am of the mindset that amphetamine is a greater neurotoxin, but I admit that this notion could be hampered by self-justifications over my personal MPH use.